BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 15522086)

  • 1. In vivo selection for Leishmania donovani miniexon genes that increase virulence in Leishmania major.
    Zhang WW; Matlashewski G
    Mol Microbiol; 2004 Nov; 54(4):1051-62. PubMed ID: 15522086
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs.
    Zhang WW; Chan KF; Song Z; Matlashewski G
    Exp Parasitol; 2011 Dec; 129(4):337-45. PubMed ID: 21978449
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screening Leishmania donovani complex-specific genes required for visceral disease.
    Zhang WW; Matlashewski G
    Methods Mol Biol; 2015; 1201():339-61. PubMed ID: 25388124
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leishmania: overexpression and comparative structural analysis of the stage-regulated meta 1 gene.
    Uliana SR; Goyal N; Freymüller E; Smith DF
    Exp Parasitol; 1999 Jul; 92(3):183-91. PubMed ID: 10403759
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Leishmania-induced cellular recruitment during the early inflammatory response: modulation of proinflammatory mediators.
    Matte C; Olivier M
    J Infect Dis; 2002 Mar; 185(5):673-81. PubMed ID: 11865425
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of the A2 gene locus in Leishmania donovani and Leishmania major and its control over cutaneous infection.
    Zhang WW; Mendez S; Ghosh A; Myler P; Ivens A; Clos J; Sacks DL; Matlashewski G
    J Biol Chem; 2003 Sep; 278(37):35508-15. PubMed ID: 12829719
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Leishmania mini-exon genes for molecular epidemiology of leishmaniasis in China and Ecuador.
    Katakura K; Kawazu SI; Sanjyoba C; Naya T; Matsumoto Y; Ito M; Nagakura K; Aikawa M; Hashiguchi Y
    Tokai J Exp Clin Med; 1998 Dec; 23(6):393-9. PubMed ID: 10622637
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Does the Leishmania major paradigm of pathogenesis and protection hold for New World cutaneous leishmaniases or the visceral disease?
    McMahon-Pratt D; Alexander J
    Immunol Rev; 2004 Oct; 201():206-24. PubMed ID: 15361243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Leishmania (Viannia) braziliensis transfectants overexpressing the miniexon gene lose virulence in vivo.
    de Toledo JS; Junqueira dos Santos AF; Rodrigues de Moura T; Antoniazi SA; Brodskyn C; Indiani de Oliveira C; Barral A; Cruz AK
    Parasitol Int; 2009 Mar; 58(1):45-50. PubMed ID: 18992366
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cross-protection against Leishmania donovani but not L. Braziliensis caused by vaccination with L. Major soluble promastigote exogenous antigens in BALB/c mice.
    Tonui WK; Titus RG
    Am J Trop Med Hyg; 2007 Mar; 76(3):579-84. PubMed ID: 17360887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Characterization of the A2-A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection.
    Zhang WW; Matlashewski G
    Mol Microbiol; 2001 Feb; 39(4):935-48. PubMed ID: 11251814
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Searching for virulence factors in the non-pathogenic parasite to humans Leishmania tarentolae.
    Azizi H; Hassani K; Taslimi Y; Najafabadi HS; Papadopoulou B; Rafati S
    Parasitology; 2009 Jun; 136(7):723-35. PubMed ID: 19416551
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adaptation of Leishmania donovani to cutaneous and visceral environments: in vivo selection and proteomic analysis.
    McCall LI; Zhang WW; Dejgaard K; Atayde VD; Mazur A; Ranasinghe S; Liu J; Olivier M; Nilsson T; Matlashewski G
    J Proteome Res; 2015 Feb; 14(2):1033-59. PubMed ID: 25536015
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Amplified fragment length polymorphism (AFLP) analysis is useful for distinguishing Leishmania species of visceral and cutaneous forms.
    Kumar A; Boggula VR; Misra P; Sundar S; Shasany AK; Dube A
    Acta Trop; 2010 Feb; 113(2):202-6. PubMed ID: 19854144
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An integrated pipeline for the development of novel panels of mapped microsatellite markers for Leishmania donovani complex, Leishmania braziliensis and Leishmania major.
    Fakhar M; Motazedian MH; Daly D; Lowe CD; Kemp SJ; Noyes HA
    Parasitology; 2008 Apr; 135(5):567-74. PubMed ID: 18371241
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Leishmania: identification of Old World species using a permissively primed intergenic polymorphic-polymerase chain reaction.
    Eisenberger CL; Jaffe CL
    Exp Parasitol; 1999 Jan; 91(1):70-7. PubMed ID: 9920044
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparative in vivo expression of amastigote up regulated Leishmania genes in three different forms of Leishmaniasis.
    Sharma P; Gurumurthy S; Duncan R; Nakhasi HL; Salotra P
    Parasitol Int; 2010 Jun; 59(2):262-4. PubMed ID: 19963076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A proteogenomic approach to map the proteome of an unsequenced pathogen - Leishmania donovani.
    Pawar H; Sahasrabuddhe NA; Renuse S; Keerthikumar S; Sharma J; Kumar GS; Venugopal A; Sekhar NR; Kelkar DS; Nemade H; Khobragade SN; Muthusamy B; Kandasamy K; Harsha HC; Chaerkady R; Patole MS; Pandey A
    Proteomics; 2012 Mar; 12(6):832-44. PubMed ID: 22539434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Specific cpb copies within the Leishmania donovani complex: evolutionary interpretations and potential clinical implications in humans.
    Hide M; Bras-Gonçalves R; Bañuls AL
    Parasitology; 2007 Mar; 134(Pt 3):379-89. PubMed ID: 17129395
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania.
    Zhang WW; Peacock CS; Matlashewski G
    PLoS Negl Trop Dis; 2008 Jun; 2(6):e248. PubMed ID: 18545684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.